Skip to Content

Amprenavir

In the US, Amprenavir (amprenavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE05

CAS registry number (Chemical Abstracts Service)

0161814-49-9

Chemical Formula

C25-H35-N3-O6-S

Molecular Weight

505

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

HIV protease inhibitor

Chemical Name

(3S)-tetrahydro-3-furyl [(S)-α-[(1R)-1-hydroxy-2-(N¹-isobutylsulfanilamido)etyl]phenetyl]carbamate (WHO)

Foreign Names

  • Amprenavirum (Latin)
  • Amprenavir (German)
  • Amprénavir (French)
  • Amprenavir (Spanish)

Generic Names

  • Amprenavir (OS: JAN, BAN, USAN)
  • Amprénavir (OS: DCF)
  • 141 W 94 (IS)
  • KVX 478 (IS)
  • VX 478 (IS)

Brand Names

  • Agemerase
    GlaxoSmithKline, Kenya
  • Agenerase
    Glaxo Group, Lithuania; GlaxoSmithKline, Brazil; GlaxoSmithKline, Greece

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide